| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 194.2 | 291.6 | 866.5 | 1,099.5 | 1,629.1 |
| Age-adjusted comparative prevalence of diabetes, % | - | 12.1 | 15.4 | 17.1 | 18.0 |
| People with undiagnosed diabetes, in 1,000s | - | - | 173.0 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 20.0 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 220.7 | 459.3 | 565.6 | 798.9 |
| Age-adjusted comparative prevalence of IGT, % | - | 8.3 | 7.2 | 7.2 | 8.0 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 655.1 | 778.1 | 1,050.8 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 9.8 | 10.1 | 10.4 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 2,118.0 | 5,704.7 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 7.3 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.1 | - | 0.1 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 0.2 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 0.7 | - | 0.6 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 1.3 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 28,578.0 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 12.1 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 857.7 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 3,380.1 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 849.8 | 942.4 | 1,234.2 |
| Total diabetes-related health expenditure, ID million | - | - | 1,899.0 | 2,105.9 | 2,758.0 |
| Diabetes-related health expenditure per person, USD | - | 544.0 | 980.7 | 1,087.6 | 1,424.4 |
| Diabetes-related health expenditure per person, ID | - | - | 2,191.6 | 2,430.4 | 3,183.0 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 3,129.0 | 3,268.4 | 5,854.1 | 6,701.1 | 8,458.9 |
| Population of children (0-14 y), in 1,000s | 2,804.0 | - | 3,296.0 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 4,346.8 | - | - |
| Complications of diabetes | |||||
| Microvascular |
| ||||
| Macrovascular |
| ||||